Home / AXSOME THERAPEUTICS, INC. (AXSM)

AXSOME THERAPEUTICS, INC. (AXSM) Technical Analysis

Updated: 2026-03-17 00:34 UTC · Last close: 158.23 (+1.38%)
AXSOME THERAPEUTICS, INC. (AXSM) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
Support
154.50
Resistance
167.96
AXSOME THERAPEUTICS, INC. (AXSM) finished the session at 158.23 (+1.38%). Price has slipped under the 50-day average but remains above the 200-day average, leaving the longer-term structure intact even as medium-term momentum softens. 20-day momentum is notably weak at -12.68%, with price remains inside its roughly 52-week range (95.65–189.10), while ATR14 volatility is running near 3.11% of price. RSI(14) is 36.9, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. Several technical formations are active right now: Double top, Cup & handle. The most important nearby levels are support at 154.50 and resistance at 167.96. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Revenue: 31.30M · Net income: -183.17M · EPS (basic): -3.68. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.
Fundamentals Snapshot
Source: sec
Company
AXSOME THERAPEUTICS, INC.
CIK (SEC ID)
0001579428
Shares Out.
50.88M
Revenue
31.30M
Net Income
-183.17M
EPS (Basic)
-3.68
Explore more
Alphabet (GOOG) technical analysisMeta Platforms (META) technical analysisTesla (TSLA) technical analysisBroadcom (AVGO) technical analysisJPMorgan Chase & Co (JPM) technical analysisVisa (V) technical analysisMastercardorporated (MA) technical analysis
WOI OPEN FULL INTERACTIVE ANALYSIS
Note: This is an algorithmic technical snapshot (not financial advice).
AXSM Chart